0%

Mouse production

The IMPC produces single-gene knockouts. To knockout genes, the IMPC is using CRISPR/Cas9 technology, a gene editing technique.

Prior to this, the gene knockout technology used by the IMPC was based on embryonic stem (ES) cells.

These strategies rely on the identification of a ‘critical’ exon common to all transcript variants that, when deleted, disrupts gene function.

You can find more information about Mouse Production in our Documentation pages.

In this video, IMPC researcher Lauryl Nutter talks about how CRISPR/Cas9 is being used by the IMPC